Search results
Results from the WOW.Com Content Network
Coverage may vary based on a person’s previous test results. However, Medicare covers a PAP smear once every 2 years for most people. Glossary of Medicare terms
Screening coverage through Part B lasts until the age of 65 years. ... plans cover the full cost of HPV testing with a Pap smear as long as the provider accepts the insurance. However, if the ...
Cervicography is no more sensitive than Pap smear screening, and has a higher false positive rate (thus increasing the number of colposcopies needed). [3] [4] Whether cervicography could have a role in countries where Pap smear screening programs are not in place depends on cost effectiveness and remained to be determined as of 1998. [4]
The task force has introduced a recommendation that women over the age of 30 test for high-risk human papilloma viruses (HPV) every five years rather than relying on pap smears to detect cervical ...
This tissue is sent for pathology testing to assign a histologic classification that is more definitive than a Pap smear result (which is a cytologic finding). HSIL generally corresponds to the histological classification of CIN 2 or 3. [citation needed] HSIL treatment involves the removal or destruction of the affected cells, usually by LEEP.
Screening is recommended for women between ages 21 and 65, regardless of age at sexual initiation or other high-risk behaviors. [17] [18] [19] For healthy women aged 21–29 who have never had an abnormal Pap smear, cervical cancer screening with cervical cytology (Pap smear) should occur every 3 years, regardless of HPV vaccination status. [11]
The Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), [1] cervical smear (BE), cervical screening (BE), [2] or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or, more rarely, anus (in both men and women). [3]
The two screening methods available are the Pap smear and testing for HPV. CIN is usually discovered by a screening test, the Pap smear. The purpose of this test is to detect potentially precancerous changes through random sampling of the transformation zone. Pap smear results may be reported using the Bethesda system (see above).